{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:02:14Z","timestamp":1781881334912,"version":"3.54.5"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijbiomac.2025.149884","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:07:21Z","timestamp":1766534841000},"page":"149884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["Antiviral potential of major royal jelly proteins"],"prefix":"10.1016","volume":"339","author":[{"given":"Noha H.","family":"Habashy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.149884_bb0005","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3390\/molecules28031510","article-title":"Current status of the bioactive properties of royal jelly\u00a0: a comprehensive review with a focus on its anticancer","volume":"28","author":"Botezan","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0010","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s13592-019-00656-1","article-title":"Molecular insights into the enhanced performance of royal jelly secretion by a stock of honeybee ( Apis mellifera ligustica) selected for increasing royal jelly production","volume":"50","author":"Zewdu","year":"2019","journal-title":"Apidologie"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0015","article-title":"Active components and biological functions of royal jelly","volume":"134","author":"Ibrahim","year":"2023","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodcont.2022.109499","article-title":"A review on Api-products\u00a0: current scenario of potential contaminants and their food safety concerns","volume":"145","author":"Sharma","year":"2023","journal-title":"Food Control"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0025","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER suite: protein structure and function prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0035","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein\u2013protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115578","article-title":"A new approach for the treatment of bleomycin-induced rat pulmonary injury by combined protein fraction of major royal jelly protein 2 and its isoform X1","volume":"167","author":"Habashy","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0045","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pro.3289","article-title":"PDBsum: structural summaries of PDB entries","volume":"27","author":"Laskowski","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/00218839.1985.11100649","article-title":"Composition of freshly harvested and commercial royal jelly","volume":"24","author":"Howe","year":"1985","journal-title":"J. Apic. Res."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0308-8146(95)00031-D","article-title":"Changes in protein components and storage stability of Royal Jelly under various conditions","volume":"54","author":"Chen","year":"1995","journal-title":"Food Chem."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0065","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/BF00180402","article-title":"Growth stimulation with honey royal jelly DIII protein of human lymphocytic cell lines in a serum-free medium","volume":"10","author":"Watanabe","year":"1996","journal-title":"Biotechnol. Tech."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/A:1007928408128","article-title":"Stimulation of cell growth in the U-937 human myeloid cell line by honey royal jelly protein","volume":"26","author":"Watanabe","year":"1998","journal-title":"Cytotechnology"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.53393\/rial.2009.v68.32716","article-title":"Vitamins B 1, B 2 , B 6 and PP contents in royal jelly","volume":"68","author":"Moreschi","year":"2009","journal-title":"Rev. Inst. Adolfo Lutz"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0080","series-title":"Asia Pacific Reg. Semin. Anal. Trace Const","first-page":"15","article-title":"Determination of biotin in royal jelly by HPLC","author":"P.","year":"1990"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jtemb.2005.08.004","article-title":"Trace and mineral elements in royal jelly and homeostatic effects","volume":"19","author":"Stocker","year":"2005","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-9994-10-72","article-title":"More than royal food - major royal jelly protein genes in sexuals and workers of the honeybee Apis mellifera","volume":"10","author":"Buttstedt","year":"2013","journal-title":"Front. Zool."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.110881","article-title":"Protection against oxidative stress and anti-aging effect in Drosophila of royal jelly-collagen peptide","volume":"135","author":"Qiu","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0100","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s000180050229","article-title":"A family of major royal jelly proteins of the honeybee Apis mellifera L.","volume":"54","author":"J Schmitzov\u00e1","year":"1998","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0105","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1038\/nature19349","article-title":"Royalactin is not a royal making of a queen","volume":"537","author":"Buttstedt","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0110","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1271\/bbb.67.2055","article-title":"350-kDa royal jelly glycoprotein (Apisin), which stimulates proliferation of human monocytes, bears the \u03b21-3galactosylated N-glycan: analysis of the N-glycosylation site","volume":"67","author":"Kimura","year":"2003","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0115","first-page":"1","article-title":"Comprehensive identification of novel proteins and N-glycosylation sites in royal jelly","volume":"15","author":"Zhang","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/insects10090282","article-title":"The effect of diet on the composition and stability of proteins secreted by honey bees in honey","volume":"10","author":"Lewkowski O","year":"2019","journal-title":"Insects"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0125","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1007\/s00216-012-6630-2","article-title":"Honey protein extraction and determination by mass spectrometry","volume":"405","author":"Chua","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0308-8146(86)90049-X","article-title":"Carbohydrate determination of royal jelly by high resolution gas chromatography (HRGC)*","volume":"19","author":"Lercker","year":"1986","journal-title":"Food Chem."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2478\/pjfns-2013-0015","article-title":"Chemical composition of royal jelly and effects of synbiotic with two different locally isolated probiotic strains on antioxidant activities","volume":"64","author":"Nabas","year":"2014","journal-title":"Pol. J. Food Nutr. Sci"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1089\/jmf.2012.2425","article-title":"Contribution of lipids in honeybee (Apis mellifera) royal jelly to health","volume":"16","author":"Li","year":"2013","journal-title":"J. Med. Food"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0145","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jep.2010.01.055","article-title":"10-Hydroxy-2-decenoic acid from royal jelly\u00a0: a potential medicine for RA","volume":"128","author":"Yang","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0150","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1080\/00218839.2020.1744241","article-title":"Insight into the chemical composition and biological properties of Mediterranean royal jelly","volume":"59","author":"El-guendouz","year":"2020","journal-title":"J. Apic. Res."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0155","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3390\/antibiotics10070822","article-title":"Pharmaceutical prospects of bee products: special focus on anticancer, antibacterial, antiviral, and antiparasitic properties","volume":"10","author":"Nainu","year":"2021","journal-title":"antibiotics"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0160","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0091-6749(95)70242-3","article-title":"Royal jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations","volume":"96","author":"Leung","year":"1995","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0165","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2147\/JAA.S346045","article-title":"A case of anaphylaxis caused by major royal jelly protein 3 of royal jelly and its coss-reactivity with honeycomb","volume":"14","author":"Da Li","year":"2021","journal-title":"J. Asthma Allergy"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0170","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.3390\/ijms25116023","article-title":"Royal jelly: biological action and health benefits","volume":"25","author":"Or\u0161oli\u0107","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.114170","article-title":"Identification of effective anti-HCV and anti-HIV royal jelly constituents and their acute toxicity evaluation in albino rats","volume":"182","author":"Habashy","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0180","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ijbiomac.2019.09.080","article-title":"Major royal-jelly protein 2 and its isoform X1 are two novel safe inhibitors for hepatitis C and B viral entry and replication","volume":"141","author":"Habashy","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0185","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/ijms21020382","article-title":"New insights into the biological and pharmaceutical properties of royal jelly","volume":"21","author":"Ahmad","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu13020543","article-title":"Health promoting properties of bee royal jelly\u00a0: food of the queens","volume":"13","author":"Collazo","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2022.105286","article-title":"Biological properties and activities of major royal jelly proteins and their derived peptides","volume":"98","author":"Mure\u015fan","year":"2022","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0200","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1039\/D2FO00999D","article-title":"Suppressing crucial oncogenes of leukemia initiator cells by major royal jelly protein 2 for mediating apoptosis in myeloid and lymphoid leukemia cells","volume":"13","author":"Abu-Serie","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0205","first-page":"112","article-title":"Greenaway, phenolic constituents and sensitizing properties of propolis, poplar balsam and balsam of Peru","volume":"15","author":"Wollenweber","year":"1990","journal-title":"Bull. Liaison-Groupe Polyphenols"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0210","first-page":"412","article-title":"Comparative analyses of chemical composition of royal jelly and drone brood","volume":"46","author":"Balkanska","year":"2013","journal-title":"Bulg. Chem. Commun."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0215","first-page":"761","article-title":"Effect of royal jelly on gentamicin-induced nephrotoxicity in rats","volume":"12","author":"Hassan","year":"2017","journal-title":"Biochem. Cell. Arch."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0220","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ijbiomac.2019.01.210","article-title":"Two purified proteins from royal jelly with in vitro dual anti-hepatic damage potency: major royal jelly protein 2 and its novel isoform X1","volume":"128","author":"Abu-Serie","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101913","article-title":"A new approach on the regulation of NF- \u03ba B and Bax protein signaling pathway activation by royal jelly in fluoride-induced pancreas damage in rats","volume":"79","author":"Aslan","year":"2022","journal-title":"Tissue Cell"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0230","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jtcme.2023.11.005","article-title":"Nootropic effect of Indian Royal Jelly against okadaic acid induced rat model of Alzheimer \u2019 s disease\u00a0: inhibition of neuroinflammation and acetylcholineesterase","volume":"14","author":"Dubey","year":"2023","journal-title":"J. Tradit. Complement. Med."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2023.102255","article-title":"Neuroprotective effects of Royal Jelly (RJ) against pentylenetetrazole (PTZ) -induced seizures in rats by targeting inflammation and oxidative stress","volume":"129","author":"Nazarinia","year":"2023","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0240","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/0005772X.1980.11097776","article-title":"Beeswax\u2014composition and analysis","volume":"61","author":"Tulloch","year":"1980","journal-title":"Bee World"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0245","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.3390\/nu14173579","article-title":"General nutritional profile of bee products and their potential antiviral properties against mammalian viruses","volume":"14","author":"Asma","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0250","series-title":"Isolation and Characterisation of Substances from Royal Jelly. PhD Thesis, Universit\u00e9 d\u2019Orl\u00e9ans; Technical University of Munich","author":"Stocker","year":"2003"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2020.104282","article-title":"The potential antiviral effect of major royal jelly protein2 and its isoform X1 against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): insight on their sialidase activity and molecular docking","volume":"75","author":"Habashy","year":"2020","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0260","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijbiomac.2022.12.251","article-title":"Major royal jelly proteins elicited suppression of SARS-CoV-2 entry and replication with halting lung injury","volume":"228","author":"Abu-Serie","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/00218839.1994.11100857","article-title":"Molecular cloning of two cDNAs from the head of the nurse honey bee (Apis mellifera L.) for coding related proteins of royal jelly","volume":"33","author":"Klaudiny","year":"1994","journal-title":"J. Apic. Res."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0270","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nature10093","article-title":"Royalactin induces queen differentiation in honeybees","volume":"473","author":"Kamakura","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0119169","article-title":"Heat resistant characteristics of major royal jelly protein 1 (MRJP1) oligomer","volume":"10","author":"Moriyama","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0280","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1271\/bbb.68.138","article-title":"Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages","volume":"68","author":"Kohno","year":"2004","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0285","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/S0024-3205(03)00562-9","article-title":"Major royal jelly protein 3 modulates immune responses in vitro and in vivo","volume":"73","author":"Okamoto","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0290","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.aspen.2019.06.005","article-title":"Antibacterial activity of major royal jelly proteins of the honeybee (Apis mellifera) royal jelly","volume":"22","author":"Park","year":"2019","journal-title":"J. Asia Pac. Entomol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0295","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jff.2011.12.007","article-title":"Bioactive compounds and health-promoting properties of royal jelly: a review","volume":"4","author":"Ramadan","year":"2012","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/11530550-000000000-00000","article-title":"Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy","volume":"24","author":"Sol\u00e1","year":"2010","journal-title":"BioDrugs"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0305","doi-asserted-by":"crossref","first-page":"9411","DOI":"10.1021\/acs.jafc.9b03080","article-title":"Site-specific analysis of N-linked glycosylation Heterogeneity from Royal Jelly Glycoproteins","volume":"67","author":"Lin","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0310","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1002\/pmic.200900541","article-title":"Molecular characteristics and physiological functions of major royal jelly protein 1 oligomer","volume":"9","author":"Tamura","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0315","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/467869","article-title":"Hepatitis C virus NS3 inhibitors: current and future perspectives","volume":"2013","author":"Salam","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0320","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/bip.22780","article-title":"New directions for protease inhibitors directed drug discovery","volume":"106","author":"Hamada","year":"2016","journal-title":"Biopolymers"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0325","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/JHC.S221187","article-title":"Hepatocellular carcinoma mechanisms associated with chronic HCV infection and the impact of direct-acting antiviral treatment","volume":"7","author":"Dash","year":"2020","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0330","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/014107680409700504","article-title":"Diagnosis and treatment of hepatitis C","volume":"97","author":"D\u2019Souza","year":"2004","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0335","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev-pharmtox-011112-140254","article-title":"Direct-acting antiviral agents for hepatitis c virus infection","volume":"53","author":"Kiser","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0340","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1128\/AAC.01058-08","article-title":"In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitory","volume":"53","author":"Lin","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0345","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hep.29109","article-title":"Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: a systematic review and meta-analysis","volume":"66","author":"Chen","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0350","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.29135","article-title":"Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals","volume":"66","author":"Belperio","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0355","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.3390\/v7102868","article-title":"Inhibitors of the hepatitis C virus polymerase; mode of action and resistance","volume":"7","author":"Eltahla","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0360","doi-asserted-by":"crossref","first-page":"12223","DOI":"10.7150\/thno.50992","article-title":"Virus-induced p38 MAPK activation facilitates viral infection","volume":"10","author":"Cheng","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0365","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1189\/jlb.0106014","article-title":"Up-regulation of ERK and p38 MAPK signaling pathways by hepatitis C virus E2 envelope protein in human T lymphoma cell line","volume":"80","author":"Zhao","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104815","article-title":"HBV replication inhibitors","volume":"179","author":"Pierra Rouviere","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0375","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0380","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000360948","article-title":"Inhibitors of hepatitis B virus attachment and entry","volume":"57","author":"Lempp","year":"2014","journal-title":"Intervirology"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0385","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrgastro.2016.7","article-title":"Global strategies are required to cure and eliminate HBV infection","volume":"13","author":"Revill","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0390","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/j.1440-1746.2011.06766.x","article-title":"Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir","volume":"26","author":"Takkenberg","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0395","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0400","first-page":"77","article-title":"Effect of royal jelly on gene expression of toll-like receptors 1-9 in patients with hepatitis B","volume":"69","author":"Naghib, Maryam","year":"2023","journal-title":"Clin. Lab."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0405","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2015.09.011","article-title":"Hepatitis B virus reverse transcriptase - target of current antiviral therapy and future drug development","volume":"123","author":"Clark","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0410","doi-asserted-by":"crossref","first-page":"W174","DOI":"10.1093\/nar\/gkv342","article-title":"I-TASSER server: new development for protein structure and function predictions","volume":"43","author":"Yang","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0415","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2217\/17460913.1.4.427","article-title":"Protective immunity against HIV infection: lessons from HIV-2 infection","volume":"1","author":"Rowland-Jones","year":"2006","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0420","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1742-4690-7-35","article-title":"Limelight on two HIV\/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?","volume":"7","author":"Ayinde","year":"2010","journal-title":"Retrovirology"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0425","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006924","article-title":"HIV-1 assembly, budding, and maturation","volume":"2","author":"Sundquist","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0430","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrmicro2747","article-title":"The structural biology of HIV-1: mechanistic and therapeutic insights","volume":"10","author":"Engelman","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0435","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/bmb\/58.1.61","article-title":"The pathogenesis of HIV-1 infection","volume":"58","author":"Weber","year":"2001","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0440","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12981-019-0239-x","article-title":"HIV-2 as a model to identify a functional HIV cure","volume":"16","author":"Esbj\u00f6rnsson","year":"2019","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0445","first-page":"95","article-title":"HIV protease inhibitors: a review of molecular selectivity and toxicity","volume":"7","author":"Lv","year":"2015","journal-title":"HIV\/AIDS - Res. Palliat. Care"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0450","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/QAD.0000000000000262","article-title":"HIV protease inhibitor exposure predicts cerebral small vessel disease","volume":"28","author":"Soontornniyomkij","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0455","first-page":"43","article-title":"Adjuvant effect of royal jelly on HIV-1 multi-epitope vaccine candidate\u00a0: induction of TH1 cytokine pattern","volume":"5","author":"Bagheri","year":"2017","journal-title":"MOJ Immunol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0460","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0465","first-page":"479","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"36","author":"Valerie","year":"2020","journal-title":"Trends Genet."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0470","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/0972063420935548","article-title":"Genetics of severe acute respiratory syndrome coronavirus-2 and diagnosis of coronavirus disease-2019: an overview","volume":"22","author":"Sewda","year":"2020","journal-title":"J. Health Manag."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0475","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jiph.2020.07.011","article-title":"The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review of the current global status","volume":"13","author":"Bchetnia","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0480","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3390\/life13071573","article-title":"Molecular insights into royal jelly anti-inflammatory properties and related diseases","volume":"13","author":"Bagameri","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0485","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2021.104514","article-title":"Active components and biological functions of royal jelly","volume":"82","author":"Guo","year":"2021","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0495","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jff.2011.12.007","article-title":"Bioactive compounds and health-promoting properties of royal jelly: a review","volume":"4","author":"Ramadan","year":"2012","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0500","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1007\/s00705-017-3417-y","article-title":"Flavonoids: promising natural compounds against viral infections","volume":"162","author":"Zakaryan","year":"2017","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0505","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijbiomac.2018.04.056","article-title":"The antiviral activity of polysaccharides and their derivatives","volume":"115","author":"Chen","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0510","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/brv.12052","article-title":"Origin and function of the major royal jelly proteins of the honeybee (Apis mellifera) as members of the yellow gene family","volume":"89","author":"Buttstedt","year":"2014","journal-title":"Biol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023710","article-title":"Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans","volume":"6","author":"Lang","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0520","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jiac.2014.08.003","article-title":"Lactoferrin for prevention of common viral infections","volume":"20","author":"Wakabayashi","year":"2014","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0525","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1074\/jbc.M411122200","article-title":"Isolation and characterization of Griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp","volume":"280","author":"Mori","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0530","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1073\/pnas.0901506106","article-title":"Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component","volume":"106","author":"O\u2019Keefe","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0535","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/v8100296","article-title":"Griffithsin: an antiviral lectin with outstanding therapeutic potential","volume":"8","author":"Lusvarghi","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0540","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-065X.2011.01082.x","article-title":"\u0391-Defensins in human innate immunity","volume":"245","author":"Lehrer","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0545","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1016\/j.jmb.2013.09.038","article-title":"Antiviral mechanisms of human Defensins","volume":"425","author":"Wilson","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0550","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1021\/acs.jafc.8b00961","article-title":"The fate of major Royal Jelly Proteins during proteolytic digestion in the human gastrointestinal tract","volume":"66","author":"Mure\u015fan","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0555","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41598-019-45460-0","article-title":"pH-dependent stability of honey bee (Apis mellifera) major royal jelly proteins","volume":"9","author":"Mure\u015fan","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0560","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1021\/jf1007133","article-title":"Expression of recombinant AccMRJP1 protein from royal jelly of Chinese honeybee in Pichia pastoris and its proliferation activity in an insect cell line","volume":"58","author":"Shen","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0565","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.aspen.2019.05.003","article-title":"Major royal jelly protein 2 acts as an antimicrobial agent and antioxidant in royal jelly","volume":"22","author":"Park","year":"2019","journal-title":"J. Asia Pac. Entomol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0570","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jchromb.2004.01.008","article-title":"Practical application of aqueous two-phase partition to process development for the recovery of biological products","volume":"807","author":"Rito-Palomares","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0575","series-title":"Protein Purification: Principles and Practice","article-title":"Springer Advanced Texts in Chemistry","author":"Scopes","year":"1994"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0580","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1021\/pr100768t","article-title":"Proteome comparison of hypopharyngeal gland development between Italian and royal jelly producing worker honeybees (Apis mellifera L.)","volume":"9","author":"Jianke","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0585","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-1656(01)00237-1","article-title":"Hydrophobic interaction chromatography of proteins","volume":"87","author":"Queiroz","year":"2001","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0590","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0595","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bios.2015.04.041","article-title":"Replacing antibodies with aptamers in lateral flow immunoassay","volume":"71","author":"Chen","year":"2015","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0600","series-title":"Antiviral, antifibrotic and anticancer activities of royal jelly proteins, U.S. Patent US20200207820A1","author":"Salem","year":"2020"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0605","series-title":"Anti-leukemic, anti-HIV, and sialidase activities of royal jelly proteins, U.S. Patent US20200399330A1","author":"El-Fiky","year":"2020"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2261","article-title":"The effects of orally administered lactoferrin in the prevention and management of viral infections: a systematic review","volume":"32","author":"Sinopoli","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu15051285","article-title":"Effect of lactoferrin on clinical outcomes of hospitalized patients with COVID-19: the LAC randomized clinical trial","volume":"15","author":"Matino","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0620","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1128\/JVI.02322-09","article-title":"Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein Griffithsin against emerging viruses of the family Coronaviridae","volume":"84","author":"O\u2019Keefe","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2020.561502","article-title":"Hantavirus infection is inhibited by Griffithsin in cell culture","volume":"10","author":"Shrivastava-Ranjan","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0630","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/BST20200884","article-title":"Defensin-lipid interactions in membrane targeting: mechanisms of action and opportunities for the development of antimicrobial and anticancer therapeutics","volume":"50","author":"Hein","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0635","doi-asserted-by":"crossref","first-page":"193","DOI":"10.55544\/jrasb.3.1.31","article-title":"The hepatic physiology and pathophysiology of different types of hepatitis","volume":"3","author":"R.M. Rashied","year":"2024","journal-title":"J. Res. Appl. Sci. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0640","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4172\/2157-7013.1000270","article-title":"Lithium treatment in clinical medicine: history, current status and future use","volume":"8","author":"Duvall","year":"2017","journal-title":"J. Cell Sci. Ther."},{"key":"10.1016\/j.ijbiomac.2025.149884_bb0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-020-01581-z","article-title":"SARS coronavirus 2: from genome to infectome","volume":"21","author":"Rastogi","year":"2020","journal-title":"Respir. Res."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025104418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025104418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:22:53Z","timestamp":1769505773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025104418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":129,"alternative-id":["S0141813025104418"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149884","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral potential of major royal jelly proteins","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149884"}}